The research aims to evaluate the pharmacokinetics of flavopiridol-loaded microparticles for joint inflammation treatment.
Evaluated pharmacokinetics of microparticle formulation in Lewis rats
Assessed sustained release and systemic effects
Monitored joint inflammation markers over time
Sustained release of flavopiridol observed over extended periods
Reduced joint inflammation indicated in treated Lewis rats
Potential for long-term management of osteoarthritis established
Abstract
The microparticle-based sustained-release formulation provides a promising means for the prevention and long-term treatment of joint inflammation and OA in both humans and animals.